Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation (VREX) delivers critical x-ray components for medical diagnostics and industrial inspection systems worldwide. This page provides investors and industry professionals with a comprehensive resource for tracking the company's latest press releases, financial announcements, and strategic developments.
Find timely updates on quarterly earnings, new product launches, and partnerships that shape Varex's leadership in imaging technology. Our curated collection includes regulatory filings, manufacturing innovations, and market expansion updates across both medical and industrial segments.
Bookmark this page to monitor how Varex's advancements in digital detectors, x-ray tubes, and quality engineering impact global healthcare and industrial inspection markets. Check regularly for objective reporting on developments affecting the medical imaging supply chain and non-destructive testing solutions.
Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q2 of fiscal 2023 on May 2, 2023, after market close. A conference call will follow at 3:00 pm Mountain Time, and interested parties can listen live via the company’s website or by phone. The conference call will be archived for future access.
Varex specializes in X-ray imaging components including tubes and digital detectors, servicing the medical, industrial, and security sectors. Headquartered in Salt Lake City, Utah, Varex employs around 2,400 personnel across North America, Europe, and Asia.
Varex Imaging Corporation (Nasdaq: VREX) announced upcoming presentations at two virtual investor conferences. The presentations will be held at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, at 12:40 pm ET, and the Sidoti Small-Cap Conference on March 23, 2023, at 2:30 pm ET. Both events will be available via live webcast on Varex’s website, with replays accessible for 90 days post-event. Varex is a leading manufacturer of X-ray imaging components used in various applications, employing around 2,300 people globally.
Varex Imaging Corporation (Nasdaq: VREX) reported its unaudited financial results for Q1 FY23. Revenues reached $206 million, reflecting an 11% sequential decline but a 3% year-over-year increase. The GAAP gross margin was 31%, while the non-GAAP gross margin stood at 32%. Operating expenses were $50 million (GAAP) and $47 million (non-GAAP). The GAAP net earnings were $0.08 per diluted share, down from $0.42 last quarter, with non-GAAP EPS at $0.21. The company anticipates Q2 revenues between $205 million and $225 million and non-GAAP EPS between $0.05 and $0.25.
Varex Imaging Corporation (Nasdaq: VREX) will announce its unaudited financial results for Q1 FY 2023 on January 31, 2023, after regular trading hours. A conference call will follow at 3:00 PM MT, accessible via the company's website or by phone. The replay will be available until February 14, 2023. Varex is a leader in X-ray imaging components, serving various applications in medical, industrial, and security sectors. Employing approximately 2,300 people globally, the company has a rich history of innovation in imaging technologies.
FAQ
What is the current stock price of Varex Imaging (VREX)?
What is the market cap of Varex Imaging (VREX)?
